Myostatin Antibody

Myostatin Polyclonal Rabbit Anti Human Antibody
Shipped with Ice Packs
In Stock

Description

Definition and Biological Target

Myostatin antibodies are monoclonal or polyclonal immunoglobulins that bind to myostatin (growth differentiation factor 8, GDF8), a member of the TGF-β superfamily encoded by the MSTN gene . By neutralizing myostatin, these antibodies block its interaction with activin type IIB receptors (ActRIIB), thereby preventing downstream signaling pathways that limit muscle growth .

Mechanism of Action

Myostatin antibodies exert dual effects on muscle homeostasis:

PathwayEffect of Myostatin InhibitionOutcome
Akt/mTORC1 SignalingRestores protein synthesisHypertrophy (muscle fiber enlargement)
Ubiquitin LigasesReduces FoxO-mediated protein degradationDecreased muscle atrophy
Satellite Cell ActivationEnhances proliferation and differentiationImproved muscle regeneration

For example, GYM329, a novel antibody, binds the latent form of myostatin and employs "sweeping antibody technology" to clear myostatin from muscles and plasma . This approach outperforms conventional antibodies by enhancing both specificity and efficacy .

Muscular Dystrophy and SMA

  • Duchenne Muscular Dystrophy (DMD): Preclinical studies in mdx mice showed a 15–25% increase in muscle mass and improved grip strength with anti-myostatin antibodies .

  • Spinal Muscular Atrophy (SMA):

    • Apitegromab: In a Phase II trial (NCT03921528), nonambulatory SMA patients receiving 20 mg/kg apitegromab + nusinersen showed improved Hammersmith Functional Motor Scale (HFMSE) scores .

    • Taldefgrobep alfa: RESILIENT trial (NCT05156320) includes ambulant and nonambulatory SMA patients, with results expected in late 2024 .

Age-Related Sarcopenia

A 4-week treatment with ATA 842 in aged mice (23 months) increased lean mass by 10% and improved insulin sensitivity .

Antibody-Specific Advancements

AntibodyTargetClinical Trial PhaseKey Benefit
GYM329 (RG-6237)Latent myostatinPhase III (NCT05115110)Enhanced muscle strength in primates
MYO-029Mature myostatinPreclinicalFirst human-tolerated antibody
ApitegromabMyostatin activationPhase III (NCT05626855)Improved motor function in SMA

Comparative Efficacy

  • GYM329 increased muscle mass in cynomolgus macaques by 12% without toxicity .

  • PF-354 (anti-myostatin antibody) improved in situ muscle strength in 21-month-old mice after 14 weeks .

Future Directions

  • Broader Indications: Expanding apitegromab trials to SMA type I/IV and RG-6237 to Spinraza-treated patients .

  • Combination Therapies: Pairing myostatin antibodies with gene therapies (e.g., Zolgensma) to amplify efficacy .

Product Specs

Introduction
GDF8, also known as Myostatin, belongs to the bone morphogenetic protein (BMP) family within the TGF-beta superfamily. These proteins share a characteristic polybasic proteolytic processing site, which upon cleavage, generates a mature protein containing seven conserved cysteine residues. Proteins in this family play crucial roles in regulating cell growth and differentiation in both embryonic and adult tissues. GDF8 is specifically known for its role as a secreted protein that negatively regulates skeletal muscle growth.
Formulation
Lyophilized from a 1 mg/ml solution in a 0.2 µm sterile filtered phosphate-buffered saline (PBS) solution.
Solubility
Reconstitute the lyophilized powder with sterile water (H₂O). Mix gently by swirling, ensuring the solution reaches the sides of the vial. Allow the solution to sit for 30-60 seconds before use.
Stability
Store the lyophilized product at 4°C. For long-term storage, aliquot the reconstituted antibody and store at -20°C. Avoid repeated freezing and thawing cycles.
Purity
The purity is determined to be greater than 98.0% by SDS-PAGE analysis.
Applications
This IgG antibody is suitable for detecting human Myostatin by Western Blot (WB) analysis. For optimal results, use a dilution of 1:500 and incubate overnight.
Synonyms
GDF-8, MSTN, Growth Differentiation Factor 8, MSTN Muscle Hypertrophy.
Purification Method
Purified IgG prepared by affinity chromatography on protein G.
Type
Polyclonal Rabbit Antibody.
Immunogen
r.Human Myostatin
Ig Subclass
Rabbit IgG
Antigen Amino Acid Sequence
HHHHHHDFGL DCDEHSTESR CCRYPLTVDF EAFGWDWIIA PKRYKANYCS GECEFVFLQK
YPHTHLVHQA NPRGSAGPCC TPTKMSPINM LYFNGKEQII YGKIPAMVVD RCGCS

Product Science Overview

Introduction

Myostatin, also known as Growth Differentiation Factor 8 (GDF-8), is a member of the Transforming Growth Factor-beta (TGF-β) superfamily. It plays a crucial role in regulating skeletal muscle growth by inhibiting muscle differentiation and growth. The Myostatin Polyclonal Rabbit Anti-Human Antibody is a valuable tool in research for detecting and studying myostatin in various biological samples.

Myostatin: The Protein

Myostatin is a secreted protein that negatively regulates muscle growth. It is synthesized as a precursor protein that undergoes proteolytic processing to produce a mature, biologically active form. The mature myostatin protein contains seven conserved cysteine residues, which are characteristic of the TGF-β superfamily. Myostatin is expressed predominantly in skeletal muscle tissues and has been shown to play a role in muscle homeostasis and development.

Polyclonal Antibodies: An Overview

Polyclonal antibodies are a mixture of immunoglobulin molecules secreted against a specific antigen, each recognizing a different epitope. They are produced by immunizing an animal (in this case, a rabbit) with the target antigen (myostatin). The animal’s immune system generates a diverse array of antibodies, which are then collected from the serum. Polyclonal antibodies are advantageous because they recognize multiple epitopes on the target antigen, increasing the likelihood of successful detection.

Production of Myostatin Polyclonal Rabbit Anti-Human Antibody

The production of the Myostatin Polyclonal Rabbit Anti-Human Antibody involves several steps:

  1. Immunization: Rabbits are immunized with a synthetic peptide corresponding to a specific region of the human myostatin protein. This peptide is often conjugated to a carrier protein, such as Keyhole Limpet Hemocyanin (KLH), to enhance the immune response.
  2. Serum Collection: After a series of booster immunizations, blood is collected from the rabbits. The serum, which contains the polyclonal antibodies, is separated from the blood cells.
  3. Purification: The antibodies are purified from the serum using techniques such as affinity chromatography. This process ensures that the final product is highly specific to myostatin and free from other serum proteins.
Applications of Myostatin Polyclonal Rabbit Anti-Human Antibody

The Myostatin Polyclonal Rabbit Anti-Human Antibody is used in various research applications, including:

  • Western Blotting: To detect myostatin protein levels in tissue and cell lysates.
  • Immunohistochemistry: To visualize myostatin expression in tissue sections.
  • ELISA: To quantify myostatin levels in biological samples.
  • Immunoprecipitation: To isolate myostatin protein complexes from cell lysates.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.